How much does a stem cell treatment cost? $5,000 is a nice round number that is probably close to the mark on average, but the price varies a great deal and depends on many factors. Factors that influence perceived average price include what one actually sees as being under that umbrella term “stem cell treatment.” Does […]
Stem cell treatment cost: you often don’t get what you pay for Read More »
Stem cell therapy cost is a moving target. A lot depends on the circumstances. Did you get the therapy at a university or major medical center or like most people these days at a stem cell clinic? Did insurance pay any of the cost and if so, how much? If not, how did you get
Stem cell therapy cost: if you got a treatment, how much did you pay? Read More »
We hear so much about exciting potential stem cell therapies, but what about stem cell treatment cost? Some of these “therapies” are rigorously evaluated ones in the FDA clinical trial pipeline and others are available right now mainly through predatory stem cell clinics. Earlier this year I posted about the cost of the offerings of
Stem cell treatment cost 2.0: legit therapy Read More »
The idea that we could bioengineer new human body parts to replace old, faulty ones is exciting, and such parts could include limbs, digits, or even entire organs. Such replacements might be produced using stem cells, 3-D printers, and other rapidly evolving, cutting edge technologies. Sci-fi is becoming a reality. Remember in Star Wars when
Will bioengineered body parts cost an arm and a leg? Read More »
How much do these stem cell treatments cost? Stem cell treatments of various kinds are now widely available in America at more than 100 stem cell clinics offering non-FDA approved interventions for dozens of conditions. American patients are often recruited on the Internet to travel around the US or to Mexico and other countries. How
How Much Do Stem Cell Treatments Really Cost? Read More »
What’s the deal on iPS cell licensure ? I’ve been researching the issue of how intellectual property (IP) and patents to iPS cell will influence the field. It’s a complicated, worrisome picture in terms of getting this technology to patients to help them. I’m concerned there may be an all out patent war. Even for
Sky’s the limit on iPS cell licensure cost from Academia Japan Read More »
The Trump Administration just quickly gutted the FDA including key leadership. What is going to be the impact of this sudden purge? Former Commissioner Robert Califf recently said it is the end of the FDA as we’ve known it. Those are dramatic words, but they seem on the money to me. As a biomedical scientist
Why the FDA & CBER leadership purge will be so bad for biotech Read More »
New FDA Commissioner Marty Makary has brought on Dr. Tracy Beth Hoeg (or Høeg) as a special assistant. Hoeg has had some controversial views on COVID. She has seemed skeptical of certain elements of vaccination, masking, and school closing. What struck me is that she also has offered unproven cell therapies at a clinic here
New Makary FDA aide Dr. Tracy Hoeg has offered unproven stem cells Read More »
I want to discuss a recent development with Humacyte and the FDA, but first, please check out a new video below that is a discussion between student Parmin Sedigh and me on the idea of stem cells for heart disease. Parmin has also written for The Niche and has her own site too. I am impressed
Weekly reads: Humacyte, retinal stem cells, stem cell therapy for knees & hearts Read More »
Peter Marks resigned last week as CBER director and now Dr. Scott Steele is the new acting biologics branch director. Marks resigned under pressure and went out firing back, referring to lies and other issues of HHS Secretary RFK Jr. One of the first things I thought when I heard about Marks’ departure was, “who